New nanoparticle therapy offers potential new treatment for aggressive breast cancer

Wednesday, January 15, 2020
(Funded by the National Institutes of Health)

Researchers at the University of Maryland School of Medicine have developed a new nanoparticle drug formulation that targets a specific receptor on cancer cells and appears to be more effective than a standard nanoparticle therapy currently on the market to treat metastatic breast cancer. The study found that the new nanoparticles bypass healthy cells and tissues and bind to tumor cells, dispersing evenly throughout the tumor while releasing the chemotherapy drug paclitaxel.